Damora Therapeutics (DMRA) Prepaid Assets (2019 - 2026)
Damora Therapeutics' (DMRA) quarterly Prepaid Assets came in at $410000.0 in Q1 2026, up 215.38% YoY from $130000.0 in Q1 2025, and down 28.94% on a QoQ basis from $577000.0 in Q4 2025.
Damora Therapeutics (DMRA) Prepaid Assets (2019 - 2026) Analysis & Trends
Damora Therapeutics (DMRA) has 8 years of Prepaid Assets data on file, last reported at $410000.0 in Q1 2026.
- Quarterly Prepaid Assets rose 215.38% year-over-year to $410000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $410000.0 (up 215.38% YoY) and the FY2025 annual result came in at $577000.0, up 541.11% from the prior year.
- Prepaid Assets declined to $410000.0 in Q1 2026, from $577000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.9 million in Q1 2023 to a low of $52000.0 in Q4 2022.
- A 5-year average of $938352.9 and a median of $339000.0 in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets tumbled 95.6% — and 2023, when it surged 1446.22%.
- Tracing DMRA's Prepaid Assets over 5 years: stood at $52000.0 in 2022, then soared by 63.46% to $85000.0 in 2023, then advanced by 5.88% to $90000.0 in 2024, then soared by 541.11% to $577000.0 in 2025, then dropped by 28.94% to $410000.0 in 2026.
- The last three Prepaid Assets figures came in at $410000.0 (Q1 2026), $577000.0 (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Damora Therapeutics | 1.92 Bn | 1.38 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.07 Mn |
| Mar 31, 2026 | 410,000.00 |
| Dec 31, 2025 | 577,000.00 |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 118,000.00 |
| Mar 31, 2025 | 130,000.00 |
| Dec 31, 2024 | 90,000.00 |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 534,000.00 |
| Dec 31, 2023 | 85,000.00 |
| Sep 30, 2023 | 109,000.00 |
| Jun 30, 2023 | 339,000.00 |
| Mar 31, 2023 | 3.88 Mn |
| Dec 31, 2022 | 52,000.00 |
| Sep 30, 2022 | 214,000.00 |
| Jun 30, 2022 | 3.18 Mn |
| Mar 31, 2022 | 251,000.00 |
| Dec 31, 2021 | 334,000.00 |
| Sep 30, 2021 | 4.86 Mn |